Extended Data Fig. 1

30 promising de novo molecules to effectively target AKT1 protein (generated by DrugGEN model), selected via expert curation from the dataset of molecules with sufficiently low binding free energies (< −8 kcal/mol) in the molecular docking experiment and deep learning-based DTI predictions (by DEEPScreen 59) as ‘active’.